Oxaliplatin: results in colorectal carcinoma
- 1 October 2002
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 44 (1) , 29-44
- https://doi.org/10.1016/s1040-8428(01)00192-5
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- OxaliplatinDrugs, 2000
- Combination of Oxaliplatin Plus Irinotecan in Patients With Gastrointestinal Tumors: Results of Two Independent Phase I Studies With PharmacokineticsJournal of Clinical Oncology, 1999
- Oxaliplatin: A review of preclinical and clinical studiesAnnals of Oncology, 1998
- Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancersAnti-Cancer Drugs, 1997
- An Information-Intensive Approach to the Molecular Pharmacology of CancerScience, 1997
- In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cellsCarcinogenesis: Integrative Cancer Research, 1996
- Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.BMJ, 1993
- Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial.Journal of Clinical Oncology, 1992
- Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethalityBiochemistry, 1990
- Phase I study of oxaliplatin in patients with advanced cancerCancer Chemotherapy and Pharmacology, 1990